News

The development of an oral formulation for use in humans aims to maximize the amount of an orally administered drug that is absorbed and then circulates in the

Synera is approved for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures such as excision, electrodessication and shave biopsy

Asparec is a recombinant, pegylated Erwinia chrysanthemi-derived asparaginase, and is currently in Phase I development for the treatment of ALL patients with hypersensitivity to standard-of-care. As per the

Earlier pre-clinical and clinical data suggested that VAL-083 may be active against a range of tumor types, including GBM. DelMar Pharma president and CEO Jeffrey Bacha said the

The review has been completed and the FDA has notified the company to proceed with the studies related to IND. The company is expected to initiate Phase III

Atorvastatin Calcium tablets, generic version of Pfizer’s Lipitor tablets, is indicated for the prevention of cardiovascular disease and hypercholesterolemia. According to IMS Health, Lipitor had US sales of

Patients with chronic, non-cancer pain, excluding those taking methadone, received lubiprostone 24mcg capsule or placebo capsule twice daily for 12 weeks. The overall spontaneous bowel movement (SBM) response

The verification system searches a global clinical database registry to identify participants that are currently enrolled in other clinical studies, improving participant selection and higher data integrity. Using

This patent relates to methods and formulations for treating migraine, symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting. The patent provides